Breath therapeutics gmbh
WebMar 20, 2024 · STARNBERG, Germany, March 20, 2024 /PRNewswire/ -- PARI Pharma, a company focused on optimization of drug-device combinations, has licensed its first-in-class inhalation development program for Bronchiolitis Obliterans Syndrome (BOS) to Breath Therapeutics GmbH (Breath Therapeutics, Munich, Germany) as their lead … WebBREATH THERAPEUTICS is a trademark owned by Breath Therapeutics GmbH and filed on Thursday, January 31, 2024 in the Pharmaceutical Products, Medical Instrument …
Breath therapeutics gmbh
Did you know?
WebBreath Therapeutics' clinical development program is addressing the treatment of Bronchiolitis Obliterans Syndrome (BOS) in patients after lung transplantation. PARI Pharma, a leading nebulizer company, is strategic partner and technology licensee for the BOS development program. Breath Therapeutics is based in Munich and Frankfurt, … WebMar 20, 2024 · MUNICH and MENLO PARK, Calif., March 20, 2024 /PRNewswire/ -- Breath Therapeutics, a private company developing advanced inhaled therapeutics in severe pulmonary orphan diseases, today...
WebBreath Therapeutics GmbH, a Zambon Group Company Mai 2024–Heute2 Jahre 5 Monate München, Bayern, Deutschland • Management of clinical trial materials for the BOSTON studies. • Oversight of... WebNov 13, 2024 · Hofstetter: Breath Therapeutics GmbH: Consultancy. Henig: Breath Therapeutics Inc.: Employment. Kappeler: Breath Therapeutics GmbH: Consultancy. …
WebFeb 20, 2024 · February 20, 2024 – Zambon, a multinational pharmaceutical company that focuses on innovation and development with the aim to improve the quality of people’s health and patients’ lives, and Breath Therapeutics, a Zambon company, specializing in advanced inhaled therapeutics for severe respiratory diseases, announced today the … WebBreakpoint Therapeutics is a company that discover and develop new anti-cancer drugs. By targeting the DNA damage response (“DDR”) in cancer cells, Breakpoint Therapeutics …
WebMar 26, 2024 · Breath Therapeutics has initiated a Phase III BOSTON clinical trials to evaluate the efficacy and safety of its drug candidate Liposomal Cyclosporine A for Inhalation (L-CsA-i) for the treatment of Bronchiolitis Obliterans Syndrome (BOS). admin BOS is caused by T-cell mediated inflammation that leads to blockage of bronchioles. …
WebBreath Therapeutics’ lead drug candidate, L-CsA-i, is a proprietary liposomal formulation of cyclosporine A for inhalation administered via a drug-specific investigational eFlow® … timothy howell eyWebApplicant: BREATH THERAPEUTICS GMBH Inventors: Martin KNOCH, Oliver DENK Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic … parrish ranch rv resort \u0026 event centerWebOct 17, 2024 · MILAN and MUNICH and MENLO PARK, Calif., Oct. 17, 2024 /PRNewswire/ -- Breath Therapeutics, a Zambon company, a biopharmaceutical company speciali... parrish ranch resortWebBreath Therapeutics is a spin-out from Munich-based PARI Pharma GmbH and specialises in advanced and first-in-class inhalation therapies for severe respiratory diseases. … parrish recyclingWebApplicant: BREATH THERAPEUTICS GMBH Inventors: Martin KNOCH, Oliver DENK Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection. Patent number: 10857198 Abstract: The invention relates to cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection. In ... parrish realty rentals zebulon ncWebJul 25, 2024 · MILAN-- ( BUSINESS WIRE )-- Zambon, a multinational pharmaceutical company that focuses on innovation and development with the aim to improve the quality of people’s health and patients’ lives, announces the acquisition of Breath Therapeutics and its subsidiaries for € 140 million (up to total € 500 million subject to regulatory and ... parrish rebecca mdWeb5 free lookups per month. No credit card required. Work. München @ Breath Therapeutics B.V. München @ Breath Therapeutics B.V. @ PARI Pharma GmbH see more Global Clinical Trial Manager @ Breath Therapeutics B.V. see less parrish realty zebulon nc listings